Search Results
Slidesets
Rationale for including immune tolerant and low viral load patients in new drug trials placeholder - Henry Lik Yeun Chan
Presented at:
International Workshop on HBV Cure 2020
Abstracts
Rifampin Urine Colorimetry for Evaluation of Tuberculosis Pharmacokinetics
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Non-Vaccine Oncogenic HPV Persistence Among HPV-Vaccinated Women Living with HIV
Presented at:
International Workshop on HIV & Women 2019
Slidesets
Barriers to Successful HIV Prevention - Community-Led Initiatives - Michael Meulbroek
Presented at:
Reducing Barriers to Successful HIV Care Forum 2022
Slidesets
Program - Viral Infections & Inflammation Workshop 2022
Presented at:
Viral Infections & Inflammation Workshop 2022
Slidesets
HIV Drug Resistance - Bench to Bedside - Leon Levin, MBBCh(Wits), FCPaed(SA), DTM&H
Presented at:
INTEREST 2021
Slidesets
Eliminating HCV Transmission by Enhancing Care and Treatment Among HCV/HIV Co-infected Individuals in Australia (not available)- Joseph Doyle, MD
Presented at:
HEP DART 2017
Slidesets
State-of-the-Art - Hepatitis B and D in People Living with HIV_Mojca Maticic
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2024
Slidesets
Eliminating the Treatment Gap_Where Do We Go and How Do We Get There - Leslie Enane.pdf
Presented at:
International Workshop on HIV & Adolescence 2023
Slidesets
Platelet Count to Spleen Diameter Ratio as a Predictor of Oesophageal Varices in Patients with Liver Cirrhosis at Muhimbili National Hospital Dar es Salaam, Tanzania
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023